FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3030406923> ?p ?o ?g. }

• W3030406923 abstract "Objectives Advanced glycation end products (AGEs) are considered a cause of diabetic osteoporosis. Although adipose-derived stem cells (ASCs) are widely used in the research of bone regeneration, the mechanisms of the osteogenic differentiation of ASCs from diabetic osteoporosis model remain unclear. This work aimed to investigate the influence and the molecular mechanisms of AGEs on the osteogenic potential of ASCs. Materials and methods Enzyme-linked immunosorbent assay was used to measure the change of AGEs in diabetic osteoporotic and control C57BL/6 mice. ASCs were obtained from the inguinal fat of C57BL/6 mice. AGEs, 5-aza2′-deoxycytidine (5-aza-dC) and DKK-1 were used to treat ASCs. Real-time cell analysis and cell counting kit-8 were used to monitor the proliferation of ASCs within and without AGEs. Real-time PCR, Western blot and Immunofluorescence were used to analyse the genes and proteins expression of osteogenic factors, DNA methylation factors and Wnt/β-catenin signalling pathway among the different groups. Results The AGEs and DNA methylation were increased in the adipose and bone tissue of the diabetic osteoporosis group. Untreated ASCs had higher cell proliferation activity than AGEs-treatment group. The expression levels of osteogenic genes, Opn and Runx2, were lower, and mineralized nodules were less in AGEs-treatment group. Meanwhile, DNA methylation was increased, and the Wnt signalling pathway markers, including β-Catenin, Lef1 and P-GSK-3β, were inhibited. After treatment with 5-aza-dC, the osteogenic differentiation capacity of ASCs in the AGEs environment was restored and the Wnt signalling pathway was activated during this process. Conclusions Advanced glycation end products inhibit the osteogenic differentiation ability of ASCs by activating DNA methylation and inhibiting Wnt/β-catenin pathway in vitro. Therefore, DNA methylation may be promising targets for the bone regeneration of ASCs with diabetic osteoporosis." @default.
• W3030406923 created "2020-06-05" @default.
• W3030406923 creator A5007909096 @default.
• W3030406923 creator A5017396497 @default.
• W3030406923 creator A5023214008 @default.
• W3030406923 creator A5043961442 @default.
• W3030406923 creator A5047440889 @default.
• W3030406923 creator A5057922659 @default.
• W3030406923 creator A5057942472 @default.
• W3030406923 creator A5058797588 @default.
• W3030406923 date "2020-05-28" @default.
• W3030406923 modified "2023-10-18" @default.
• W3030406923 title "Advanced glycation end products inhibit the osteogenic differentiation potential of adipose‐derived stem cells by modulating Wnt/β‐catenin signalling pathway via DNA methylation" @default.
• W3030406923 cites W1474372810 @default.
• W3030406923 cites W1980348526 @default.
• W3030406923 cites W2045616244 @default.
• W3030406923 cites W2046561158 @default.
• W3030406923 cites W2055171457 @default.
• W3030406923 cites W2077249217 @default.
• W3030406923 cites W2079790359 @default.
• W3030406923 cites W2134087142 @default.
• W3030406923 cites W2412611050 @default.
• W3030406923 cites W2443005784 @default.
• W3030406923 cites W2519616827 @default.
• W3030406923 cites W2529327478 @default.
• W3030406923 cites W2571637918 @default.
• W3030406923 cites W2597714851 @default.
• W3030406923 cites W2610204461 @default.
• W3030406923 cites W2773992150 @default.
• W3030406923 cites W2781877033 @default.
• W3030406923 cites W2782117612 @default.
• W3030406923 cites W2782146434 @default.
• W3030406923 cites W2791266018 @default.
• W3030406923 cites W2808098739 @default.
• W3030406923 cites W2883984970 @default.
• W3030406923 cites W2912006566 @default.
• W3030406923 cites W2924089686 @default.
• W3030406923 cites W2928880306 @default.
• W3030406923 cites W2956473282 @default.
• W3030406923 cites W2966992518 @default.
• W3030406923 cites W2986064068 @default.
• W3030406923 cites W2992037378 @default.
• W3030406923 cites W2999044578 @default.
• W3030406923 cites W3000266053 @default.
• W3030406923 cites W3002936861 @default.
• W3030406923 cites W3005065147 @default.
• W3030406923 cites W3005431294 @default.
• W3030406923 cites W3005741158 @default.
• W3030406923 cites W3006575427 @default.
• W3030406923 cites W3007498336 @default.
• W3030406923 cites W3007904241 @default.
• W3030406923 cites W3030406923 @default.
• W3030406923 cites W959211720 @default.
• W3030406923 doi "https://doi.org/10.1111/cpr.12834" @default.
• W3030406923 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7309593" @default.
• W3030406923 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32468637" @default.
• W3030406923 hasPublicationYear "2020" @default.
• W3030406923 type Work @default.
• W3030406923 sameAs 3030406923 @default.
• W3030406923 citedByCount "36" @default.
• W3030406923 countsByYear W30304069232020 @default.
• W3030406923 countsByYear W30304069232021 @default.
• W3030406923 countsByYear W30304069232022 @default.
• W3030406923 countsByYear W30304069232023 @default.
• W3030406923 crossrefType "journal-article" @default.
• W3030406923 hasAuthorship W3030406923A5007909096 @default.
• W3030406923 hasAuthorship W3030406923A5017396497 @default.
• W3030406923 hasAuthorship W3030406923A5023214008 @default.
• W3030406923 hasAuthorship W3030406923A5043961442 @default.
• W3030406923 hasAuthorship W3030406923A5047440889 @default.
• W3030406923 hasAuthorship W3030406923A5057922659 @default.
• W3030406923 hasAuthorship W3030406923A5057942472 @default.
• W3030406923 hasAuthorship W3030406923A5058797588 @default.
• W3030406923 hasBestOaLocation W30304069231 @default.
• W3030406923 hasConcept C104317684 @default.
• W3030406923 hasConcept C134018914 @default.
• W3030406923 hasConcept C137620995 @default.
• W3030406923 hasConcept C147990577 @default.
• W3030406923 hasConcept C150194340 @default.
• W3030406923 hasConcept C171089720 @default.
• W3030406923 hasConcept C185592680 @default.
• W3030406923 hasConcept C190727270 @default.
• W3030406923 hasConcept C2776363554 @default.
• W3030406923 hasConcept C2776997535 @default.
• W3030406923 hasConcept C28328180 @default.
• W3030406923 hasConcept C502942594 @default.
• W3030406923 hasConcept C55493867 @default.
• W3030406923 hasConcept C555293320 @default.
• W3030406923 hasConcept C62478195 @default.
• W3030406923 hasConcept C86803240 @default.
• W3030406923 hasConcept C95444343 @default.
• W3030406923 hasConceptScore W3030406923C104317684 @default.
• W3030406923 hasConceptScore W3030406923C134018914 @default.
• W3030406923 hasConceptScore W3030406923C137620995 @default.
• W3030406923 hasConceptScore W3030406923C147990577 @default.
• W3030406923 hasConceptScore W3030406923C150194340 @default.
• W3030406923 hasConceptScore W3030406923C171089720 @default.
• W3030406923 hasConceptScore W3030406923C185592680 @default.
• W3030406923 hasConceptScore W3030406923C190727270 @default.
• W3030406923 hasConceptScore W3030406923C2776363554 @default.

• next